$8.740
-0.419 (-4.79%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
BridgeBio Oncology Therapeutics Inc (BBOT) Moving Averages Convergence Divergence (MACD) indicator is 0.13, suggesting BBOT is Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 20-Day simple moving average is 9.09, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $—, making it Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 60-Day simple moving average is 8.44, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $—, making it Buy.
Technical Analysis for BBOT
AI Technical BBOTAs of 2026-08-29, the technical board for BridgeBio Oncology Therapeutics Inc (BBOT) reads sell: 3 indicators are flashing buy, 6 are indicating sell, and 4 are neutral. Price at $8.74 sits below the 5-day, 10-day, 20-day and 200-day moving averages and above the 60-day.
Momentum readings: RSI stands at 46.363, MACD stands at 0.132 (Buy), Stochastic %K stands at 30.1, Stochastic %D stands at 42.356 and CCI stands at -78.652.
BBOT trades above the 60-day SMA (8.44) and below the 200-day SMA (9.88). Immediate resistance sits at Classic R1 9.72, then R2 10.29. Support sits at Classic S1 8.63, then S2 8.11.
BridgeBio Oncology Therapeutics Inc (BBOT) Support & Resistance Level
BridgeBio Oncology Therapeutics Inc (BBOT) Technical Indicators
2026-08-29
| Name | Value |
|---|---|
| RSI_14 | 46.363 |
| STOCHk_14_3_3 | 30.100 |
| STOCHd_14_3_3 | 42.356 |
| CCI_20 | -78.652 |
| AO_5_34 | 0.254 |
| MOM_10 | -0.320 |
| MACD_12_26_9 | 0.132 |
BridgeBio Oncology Therapeutics Inc (BBOT) Relative Strength Index (RSI_14) is 46.363, creating a Neutral signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Stochastic %K is 30.100, creating a Neutral signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Stochastic %D is 42.356, creating a Neutral signal.
BridgeBio Oncology Therapeutics Inc (BBOT) CCI_20 is -78.652, creating a Neutral signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Awesome Oscillator (AO) is 0.254, creating a Buy signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Momentum (MOM) is -0.320, creating a Sell signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Moving Average Convergence Divergence (MACD) is 0.132, creating a Buy signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Moving Average
2026-08-29
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 9.138 | Sell |
| MA_10 | 9.144 | Sell |
| MA_20 | 9.091 | Sell |
| MA_60 | 8.442 | Buy |
| MA_200 | 9.879 | Sell |
| MA_250 | 10.170 | Sell |
BridgeBio Oncology Therapeutics Inc (BBOT) 5-Day simple moving average is 9.138, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 10-Day simple moving average is 9.144, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 20-Day simple moving average is 9.091, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 60-Day simple moving average is 8.442, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Buy.
BridgeBio Oncology Therapeutics Inc (BBOT) 200-Day simple moving average is 9.879, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 250-Day simple moving average is 10.170, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.